Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 500 results in range #1 to #500.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Attributable risk‏‎ (1 revision)
  2. ICRP Publication 101‏‎ (1 revision)
  3. Best available techniques‏‎ (1 revision)
  4. ICRP Publication 113‏‎ (1 revision)
  5. Bronchiolar region‏‎ (1 revision)
  6. Quasi-threshold dose‏‎ (1 revision)
  7. ICRP Publication 128‏‎ (1 revision)
  8. ICRP Publication 142‏‎ (1 revision)
  9. Compartment‏‎ (1 revision)
  10. Radon progeny‏‎ (1 revision)
  11. ICRP Publication 17‏‎ (1 revision)
  12. Count median diameter‏‎ (1 revision)
  13. Reference parameter value‏‎ (1 revision)
  14. ICRP Publication 30 (Index)‏‎ (1 revision)
  15. ICRP Publication 38‏‎ (1 revision)
  16. ICRP Publication 52‏‎ (1 revision)
  17. Dose commitment‏‎ (1 revision)
  18. ICRP Publication 67‏‎ (1 revision)
  19. Doubling dose‏‎ (1 revision)
  20. ICRP Publication 81‏‎ (1 revision)
  21. Supervised area‏‎ (1 revision)
  22. Evacuation‏‎ (1 revision)
  23. Thoron progeny‏‎ (1 revision)
  24. Exposure index‏‎ (1 revision)
  25. AML/eto‏‎ (1 revision)
  26. Transgenerational effect‏‎ (1 revision)
  27. Frequent flyer‏‎ (1 revision)
  28. Non-homologous end joining‏‎ (1 revision)
  29. Optimisation of protection‏‎ (1 revision)
  30. Phantom‏‎ (1 revision)
  31. ICRP Publication 101a‏‎ (1 revision)
  32. ICRP Publication 114‏‎ (1 revision)
  33. ICRP Publication 129‏‎ (1 revision)
  34. ICRP Publication 143‏‎ (1 revision)
  35. Compartment (environmental)‏‎ (1 revision)
  36. Ras‏‎ (1 revision)
  37. ICRP Publication 18‏‎ (1 revision)
  38. Cross section‏‎ (1 revision)
  39. Reference phantom‏‎ (1 revision)
  40. ICRP Publication 30 (Part 1)‏‎ (1 revision)
  41. Deposition‏‎ (1 revision)
  42. ICRP Publication 90‏‎ (1 revision)
  43. ICRP Publication 39‏‎ (1 revision)
  44. Digital breast tomosynthesis‏‎ (1 revision)
  45. ICRP Publication 53‏‎ (1 revision)
  46. Size-specific dose estimate‏‎ (1 revision)
  47. ICRP Publication 68‏‎ (1 revision)
  48. Specific absorbed fraction‏‎ (1 revision)
  49. ICRP Publication 82‏‎ (1 revision)
  50. Surface contamination‏‎ (1 revision)
  51. Excess absolute risk‏‎ (1 revision)
  52. Exposure pathway‏‎ (1 revision)
  53. Translocation‏‎ (1 revision)
  54. Multistage carcinogenesis model‏‎ (1 revision)
  55. Functional subunits‏‎ (1 revision)
  56. Activity median aerodynamic diameter‏‎ (1 revision)
  57. Ground-level enhancement‏‎ (1 revision)
  58. Homologous recombination‏‎ (1 revision)
  59. Authorised discharge‏‎ (1 revision)
  60. ICRP Publication 101b‏‎ (1 revision)
  61. Principles of protection‏‎ (1 revision)
  62. ICRP Publication 115‏‎ (1 revision)
  63. Radiation-induced second cancer‏‎ (1 revision)
  64. ICRP Publication 13‏‎ (1 revision)
  65. Clinical audit‏‎ (1 revision)
  66. ICRP Publication 144‏‎ (1 revision)
  67. Rb‏‎ (1 revision)
  68. ICRP Publication 19‏‎ (1 revision)
  69. Reference value‏‎ (1 revision)
  70. ICRP Publication 30 (Part 2)‏‎ (1 revision)
  71. ICRP Publication 91‏‎ (1 revision)
  72. ICRP Publication 4‏‎ (1 revision)
  73. ICRP Publication 54‏‎ (1 revision)
  74. Slice‏‎ (1 revision)
  75. ICRP Publication 69‏‎ (1 revision)
  76. ICRP Publication 83‏‎ (1 revision)
  77. Threshold level‏‎ (1 revision)
  78. Organ at risk‏‎ (1 revision)
  79. Pilomatricoma‏‎ (1 revision)
  80. ICRP Publication 102‏‎ (1 revision)
  81. ICRP Publication 116‏‎ (1 revision)
  82. Radiation-induced secondary malignancy‏‎ (1 revision)
  83. ICRP Publication 130‏‎ (1 revision)
  84. Radiological attack‏‎ (1 revision)
  85. ICRP Publication 145‏‎ (1 revision)
  86. Reactive oxygen species‏‎ (1 revision)
  87. ICRP Publication 2‏‎ (1 revision)
  88. Reference worker‏‎ (1 revision)
  89. ICRP Publication 30 (Part 3)‏‎ (1 revision)
  90. Derived consideration reference level‏‎ (1 revision)
  91. ICRP Publication 92‏‎ (1 revision)
  92. ICRP Publication 40‏‎ (1 revision)
  93. ICRP Publication 55‏‎ (1 revision)
  94. Dose conversion convention‏‎ (1 revision)
  95. Informed consent‏‎ (1 revision)
  96. ICRP Publication 7‏‎ (1 revision)
  97. Spongiosa‏‎ (1 revision)
  98. ICRP Publication 84‏‎ (1 revision)
  99. Exclusion‏‎ (1 revision)
  100. Marrow cellularity‏‎ (1 revision)
  101. Multitarget equation‏‎ (1 revision)
  102. Acute exposure‏‎ (1 revision)
  103. Allometry‏‎ (1 revision)
  104. Biological half-life‏‎ (1 revision)
  105. ICRP Publication 117‏‎ (1 revision)
  106. ICRP Publication 131‏‎ (1 revision)
  107. Radiological controlled area‏‎ (1 revision)
  108. ICRP Publication 146‏‎ (1 revision)
  109. Concentration ratio‏‎ (1 revision)
  110. ICRP Publication 20‏‎ (1 revision)
  111. Referrer‏‎ (1 revision)
  112. ICRP Publication 30 (Part 4)‏‎ (1 revision)
  113. Derived investigation level‏‎ (1 revision)
  114. ICRP Publication 93‏‎ (1 revision)
  115. ICRP Publication 41‏‎ (1 revision)
  116. Directional dose equivalent‏‎ (1 revision)
  117. ICRU 4-element tissue‏‎ (1 revision)
  118. ICRP Publication 56‏‎ (1 revision)
  119. Dose conversion factor‏‎ (1 revision)
  120. ICRP Publication 70‏‎ (1 revision)
  121. Effect modifier‏‎ (1 revision)
  122. ICRP Publication 85‏‎ (1 revision)
  123. Endosteum‏‎ (1 revision)
  124. System of radiological protection‏‎ (1 revision)
  125. Time-resolved computed tomography‏‎ (1 revision)
  126. Mutation component‏‎ (1 revision)
  127. Waste management‏‎ (1 revision)
  128. Normal tissue complication probability‏‎ (1 revision)
  129. Human Alimentary Tract Model‏‎ (1 revision)
  130. ICRP Publication 104‏‎ (1 revision)
  131. Biomarker‏‎ (1 revision)
  132. ICRP Publication 132‏‎ (1 revision)
  133. Clonogenic surviving fraction‏‎ (1 revision)
  134. ICRP Publication 147‏‎ (1 revision)
  135. Cone beam computed tomography‏‎ (1 revision)
  136. ICRP Publication 21‏‎ (1 revision)
  137. Region‏‎ (1 revision)
  138. ICRP Publication 30 (Supplement A to Part 3)‏‎ (1 revision)
  139. Derived limit‏‎ (1 revision)
  140. ICRP Publication 94‏‎ (1 revision)
  141. ICRP Publication 42‏‎ (1 revision)
  142. ICRU sphere‏‎ (1 revision)
  143. ICRP Publication 57‏‎ (1 revision)
  144. ICRP Publication 71‏‎ (1 revision)
  145. ICRP Publication 86‏‎ (1 revision)
  146. Treatment preparation in radiotherapy‏‎ (1 revision)
  147. Notification value‏‎ (1 revision)
  148. Other (systemic) tissues‏‎ (1 revision)
  149. Human Respiratory Tract Model‏‎ (1 revision)
  150. Automatic exposure control‏‎ (1 revision)
  151. Pooled analysis‏‎ (1 revision)
  152. ICRP Publication 105‏‎ (1 revision)
  153. ICRP Publication 119‏‎ (1 revision)
  154. Radiation risk‏‎ (1 revision)
  155. ICRP Publication 133‏‎ (1 revision)
  156. ICRP Publication 148‏‎ (1 revision)
  157. ICRP Publication 22‏‎ (1 revision)
  158. Regional diagnostic reference levels‏‎ (1 revision)
  159. ICRP Publication 30 (Supplement B to Part 3)‏‎ (1 revision)
  160. Derived reference level‏‎ (1 revision)
  161. ICRP Publication 95‏‎ (1 revision)
  162. ICRP Publication 43‏‎ (1 revision)
  163. Disposal facility‏‎ (1 revision)
  164. Sealed source‏‎ (1 revision)
  165. ICRP Publication 58‏‎ (1 revision)
  166. Solar flare‏‎ (1 revision)
  167. ICRP Publication 72‏‎ (1 revision)
  168. ICRP Publication 87‏‎ (1 revision)
  169. Linear dose response‏‎ (1 revision)
  170. Mean glandular dose‏‎ (1 revision)
  171. Absorption Type‏‎ (1 revision - redirect page)
  172. Trophic level‏‎ (1 revision)
  173. Additional dose‏‎ (1 revision)
  174. Nuclear medicine‏‎ (1 revision)
  175. Ambient dose equivalent‏‎ (1 revision)
  176. Oxygen enhancement ratio‏‎ (1 revision)
  177. Population risk‏‎ (1 revision)
  178. ICRP Publication 106‏‎ (1 revision)
  179. ICRP Publication 12‏‎ (1 revision)
  180. ICRP Publication 134‏‎ (1 revision)
  181. Cobblestone area forming cell assay‏‎ (1 revision)
  182. ICRP Publication 149‏‎ (1 revision)
  183. ICRP Publication 23‏‎ (1 revision)
  184. DRL quantity‏‎ (1 revision)
  185. Registry‏‎ (1 revision)
  186. ICRP Publication 30 (Supplement to Part 1)‏‎ (1 revision)
  187. Designated area‏‎ (1 revision)
  188. ICRP Publication 96‏‎ (1 revision)
  189. ICRP Publication 44‏‎ (1 revision)
  190. Distribution coefficient‏‎ (1 revision)
  191. Secondary radiation‏‎ (1 revision)
  192. ICRP Publication 59‏‎ (1 revision)
  193. Intake‏‎ (1 revision)
  194. ICRP Publication 73‏‎ (1 revision)
  195. Standard-size adult‏‎ (1 revision)
  196. ICRP Publication 88‏‎ (1 revision)
  197. Epigenetic effects‏‎ (1 revision)
  198. 1928 Recommendations‏‎ (1 revision)
  199. Tissue reaction‏‎ (1 revision)
  200. Measured quantity‏‎ (1 revision)
  201. Tumour suppressor gene‏‎ (1 revision)
  202. National DRL‏‎ (1 revision)
  203. Additive risk projection model‏‎ (1 revision)
  204. Potential alpha energy concentration‏‎ (1 revision)
  205. ICRP Publication 107‏‎ (1 revision)
  206. ICRP Publication 120‏‎ (1 revision)
  207. Carers and comforters‏‎ (1 revision)
  208. ICRP Publication 135‏‎ (1 revision)
  209. ICRP Publication 15‏‎ (1 revision)
  210. Redox‏‎ (1 revision)
  211. ICRP Publication 24‏‎ (1 revision)
  212. ICRP Publication 30 (Supplement to Part 2)‏‎ (1 revision)
  213. Detector quantum efficiency‏‎ (1 revision)
  214. ICRP Publication 97‏‎ (1 revision)
  215. ICRP Publication 45‏‎ (1 revision)
  216. Secretory cells‏‎ (1 revision)
  217. ICRP Publication 6‏‎ (1 revision)
  218. Intensity-modulated radiotherapy‏‎ (1 revision)
  219. ICRP Publication 74‏‎ (1 revision)
  220. Stem cell‏‎ (1 revision)
  221. Kerma approximation‏‎ (1 revision)
  222. ICRP Publication 89‏‎ (1 revision)
  223. Exogenous excretion‏‎ (1 revision)
  224. 1931 Recommendations‏‎ (1 revision)
  225. National radon survey‏‎ (1 revision)
  226. Adenoma‏‎ (1 revision)
  227. Particle transport‏‎ (1 revision)
  228. ICRP Publication 108‏‎ (1 revision)
  229. Brachytherapy‏‎ (1 revision)
  230. ICRP Publication 121‏‎ (1 revision)
  231. Case–control study‏‎ (1 revision)
  232. ICRP Publication 136‏‎ (1 revision)
  233. Collective dose‏‎ (1 revision)
  234. ICRP Publication 150‏‎ (1 revision)
  235. ICRP Publication 25‏‎ (1 revision)
  236. Relative biological effectiveness‏‎ (1 revision)
  237. ICRP Publication 31‏‎ (1 revision)
  238. Deterministic effect‏‎ (1 revision)
  239. ICRP Publication 98‏‎ (1 revision)
  240. ICRP Publication 46‏‎ (1 revision)
  241. ICRP Publication 60‏‎ (1 revision)
  242. Dose modifying factor‏‎ (1 revision)
  243. Somatic effect‏‎ (1 revision)
  244. ICRP Publication 75‏‎ (1 revision)
  245. ICRP Publication 9‏‎ (1 revision)
  246. Targeted effects‏‎ (1 revision)
  247. 1934 Recommendations‏‎ (1 revision)
  248. Access control‏‎ (1 revision)
  249. Typical value‏‎ (1 revision)
  250. General Information: Radon‏‎ (1 revision - redirect page)
  251. Annual intake‏‎ (1 revision)
  252. ICRP Publication 109‏‎ (1 revision)
  253. ICRP Publication 122‏‎ (1 revision)
  254. ICRP Publication 137‏‎ (1 revision)
  255. Radon-prone area‏‎ (1 revision)
  256. ICRP Publication 151‏‎ (1 revision)
  257. Reference Person‏‎ (1 revision)
  258. ICRP Publication 26‏‎ (1 revision)
  259. DS86‏‎ (1 revision)
  260. Relative life lost‏‎ (1 revision)
  261. ICRP Publication 32‏‎ (1 revision)
  262. ICRP Publication 99‏‎ (1 revision)
  263. ICRP Publication 47‏‎ (1 revision)
  264. Security screening‏‎ (1 revision)
  265. ICRP Publication 61‏‎ (1 revision)
  266. ICRP Publication 76‏‎ (1 revision)
  267. Stochastic effect‏‎ (1 revision)
  268. Equilibrium equivalent concentration‏‎ (1 revision)
  269. Expanded radiation field‏‎ (1 revision)
  270. 1937 Recommendations‏‎ (1 revision)
  271. Tolerance dose‏‎ (1 revision)
  272. Adventitious source‏‎ (1 revision)
  273. Occupancy factor‏‎ (1 revision)
  274. Backscatter factor‏‎ (1 revision)
  275. Potentially lethal damage repair‏‎ (1 revision)
  276. ICRP Publication 10A‏‎ (1 revision)
  277. ICRP Publication 123‏‎ (1 revision)
  278. Charged-particle equilibrium‏‎ (1 revision)
  279. ICRP Publication 138‏‎ (1 revision)
  280. Collimation‏‎ (1 revision)
  281. ICRP Publication 152‏‎ (1 revision)
  282. ICRP Publication 27‏‎ (1 revision)
  283. Relative risk‏‎ (1 revision)
  284. ICRP Publication 33‏‎ (1 revision)
  285. Detriment-adjusted risk‏‎ (1 revision)
  286. Ring chromosome‏‎ (1 revision)
  287. ICRP Supporting Guidance 2‏‎ (1 revision)
  288. ICRP Publication 48‏‎ (1 revision)
  289. Dose-response function‏‎ (1 revision)
  290. ICRP Publication 62‏‎ (1 revision)
  291. International Commission on Radiological Protection‏‎ (1 revision)
  292. ICRP Publication 77‏‎ (1 revision)
  293. Lag‏‎ (1 revision)
  294. Equilibrium factor‏‎ (1 revision)
  295. Teratocarcinoma‏‎ (1 revision)
  296. Low dose‏‎ (1 revision)
  297. 1950 Recommendations‏‎ (1 revision)
  298. Apoptosis‏‎ (1 revision)
  299. ICRP Publication 11‏‎ (1 revision)
  300. ICRP Publication 124‏‎ (1 revision)
  301. ICRP Publication 139‏‎ (1 revision)
  302. ICRP Publication 153‏‎ (1 revision)
  303. ICRP Publication 28‏‎ (1 revision)
  304. Relative survival‏‎ (1 revision)
  305. ICRP Publication 34‏‎ (1 revision)
  306. ICRP Publication 49‏‎ (1 revision)
  307. ICRP Publication 63‏‎ (1 revision)
  308. Source region‏‎ (1 revision)
  309. ICRP Publication 78‏‎ (1 revision)
  310. Elemental dose‏‎ (1 revision)
  311. Late normal tissue responses‏‎ (1 revision)
  312. Exposed individuals‏‎ (1 revision)
  313. 1954 Recommendations‏‎ (1 revision)
  314. Α/β value‏‎ (1 revision)
  315. Oncogene‏‎ (1 revision)
  316. Pencil beam‏‎ (1 revision)
  317. ICRP Publication 1‏‎ (1 revision)
  318. Baseline disease rates‏‎ (1 revision)
  319. Practice‏‎ (1 revision)
  320. ICRP Publication 110‏‎ (1 revision)
  321. Breakpoint cluster region/abelson‏‎ (1 revision)
  322. ICRP Publication 125‏‎ (1 revision)
  323. ICRP Publication 14‏‎ (1 revision)
  324. Commissioning‏‎ (1 revision)
  325. ICRP Publication 154‏‎ (1 revision)
  326. Cosmic radiation‏‎ (1 revision)
  327. ICRP Publication 29‏‎ (1 revision)
  328. ICRP Publication 35‏‎ (1 revision)
  329. ICRP Publication 5‏‎ (1 revision)
  330. Dose-threshold hypothesis‏‎ (1 revision)
  331. Severe deterministic injury‏‎ (1 revision)
  332. ICRP Publication 64‏‎ (1 revision)
  333. Intervention‏‎ (1 revision)
  334. ICRP Publication 79‏‎ (1 revision)
  335. Sublethal damage repair‏‎ (1 revision)
  336. 1956 Recommendations‏‎ (1 revision)
  337. Transfer of risk‏‎ (1 revision)
  338. Molecular imaging‏‎ (1 revision)
  339. Activation‏‎ (1 revision)
  340. Noise‏‎ (1 revision)
  341. ΓH2AX foci‏‎ (1 revision)
  342. Operating management‏‎ (1 revision)
  343. Hereditary effect‏‎ (1 revision)
  344. ICRP Publication 10‏‎ (1 revision)
  345. ICRP Publication 111‏‎ (1 revision)
  346. Quality control testing‏‎ (1 revision)
  347. ICRP Publication 126‏‎ (1 revision)
  348. Radioactive waste‏‎ (1 revision)
  349. ICRP Publication 140‏‎ (1 revision)
  350. ICRP Publication 155‏‎ (1 revision)
  351. ICRP Publication 3‏‎ (1 revision)
  352. ICRP Publication 36‏‎ (1 revision)
  353. Dicentric chromosome‏‎ (1 revision)
  354. Risk model‏‎ (1 revision)
  355. ICRP Publication 50‏‎ (1 revision)
  356. Dose and dose-rate effectiveness factor‏‎ (1 revision)
  357. Sheltering‏‎ (1 revision)
  358. Induced genomic instability‏‎ (1 revision)
  359. ICRP Publication 65‏‎ (1 revision)
  360. ICRP Publication 8‏‎ (1 revision)
  361. Licensee‏‎ (1 revision)
  362. Thermodynamic diameter‏‎ (1 revision)
  363. Low linear energy transfer radiation‏‎ (1 revision)
  364. 1959 Decisions‏‎ (1 revision)
  365. Nominal risk coefficient‏‎ (1 revision)
  366. ICRP Publication 100‏‎ (1 revision)
  367. ICRP Publication 112‏‎ (1 revision)
  368. ICRP Publication 127‏‎ (1 revision)
  369. ICRP Publication 141‏‎ (1 revision)
  370. ICRP Publication 16‏‎ (1 revision)
  371. ICRP Publication 30‏‎ (1 revision)
  372. Dental and maxillofacial imaging‏‎ (1 revision)
  373. ICRP Publication 37‏‎ (1 revision)
  374. ICRPædia Guide to Radiological Protection in Healthcare‏‎ (1 revision - redirect page)
  375. ICRP Publication 51‏‎ (1 revision)
  376. Shielding‏‎ (1 revision)
  377. ICRP Publication 66‏‎ (1 revision)
  378. ICRP Publication 80‏‎ (1 revision)
  379. Superposition principle‏‎ (1 revision)
  380. Life Span Study‏‎ (1 revision)
  381. Thoracic airways‏‎ (1 revision)
  382. Multifactorial diseases‏‎ (1 revision)
  383. Active detection system‏‎ (1 revision)
  384. Nominal value‏‎ (1 revision)
  385. High level waste‏‎ (2 revisions)
  386. Clearance‏‎ (2 revisions)
  387. Deontological Ethics‏‎ (2 revisions)
  388. Repopulation‏‎ (2 revisions)
  389. Differentiation‏‎ (2 revisions)
  390. Routine monitoring‏‎ (2 revisions)
  391. ICRPædia Guide to Radon‏‎ (2 revisions)
  392. Special (non-routine) monitoring‏‎ (2 revisions)
  393. Lifetime risk‏‎ (2 revisions)
  394. Macrophage colony stimulating factor‏‎ (2 revisions)
  395. Multiplicative risk projection model‏‎ (2 revisions)
  396. Activity‏‎ (2 revisions)
  397. Beta-minus decay‏‎ (2 revisions)
  398. Clearance level‏‎ (2 revisions)
  399. Radiographer‏‎ (2 revisions)
  400. Representative organism (non-human biota)‏‎ (2 revisions)
  401. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  402. Dose constraint‏‎ (2 revisions)
  403. Early normal tissue responses‏‎ (2 revisions)
  404. Threshold dose for tissue reactions‏‎ (2 revisions)
  405. Magnetosphere‏‎ (2 revisions)
  406. Pharynx‏‎ (2 revisions)
  407. Beta-plus decay‏‎ (2 revisions)
  408. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  409. Cumulative dose‏‎ (2 revisions)
  410. Representative person‏‎ (2 revisions)
  411. Safety‏‎ (2 revisions)
  412. Dose conversion coefficient‏‎ (2 revisions)
  413. Edema‏‎ (2 revisions)
  414. Specific effective energy‏‎ (2 revisions)
  415. Limitation of dose‏‎ (2 revisions)
  416. Excess relative risk‏‎ (2 revisions)
  417. Exposure situation‏‎ (2 revisions)
  418. Transmission detection system‏‎ (2 revisions)
  419. Multistage tumorigenesis‏‎ (2 revisions)
  420. Non-sphericity parameter‏‎ (2 revisions)
  421. Growth factor‏‎ (2 revisions)
  422. Alimentary tract transfer factor‏‎ (2 revisions)
  423. Hormones‏‎ (2 revisions)
  424. Authorization‏‎ (2 revisions)
  425. Procedural values‏‎ (2 revisions)
  426. Clonogenic cells‏‎ (2 revisions)
  427. Curie‏‎ (2 revisions)
  428. Reproductive integrity‏‎ (2 revisions)
  429. Safety case‏‎ (2 revisions)
  430. Slow repair‏‎ (2 revisions)
  431. Effect Dose 50‏‎ (2 revisions)
  432. Isotropic geometry‏‎ (2 revisions)
  433. Endogeneous excretion‏‎ (2 revisions)
  434. Lineal energy‏‎ (2 revisions)
  435. Thyroid blocking‏‎ (2 revisions)
  436. Exposure to Radon at Home‏‎ (2 revisions)
  437. Transparency‏‎ (2 revisions)
  438. GATA binding protein 2‏‎ (2 revisions)
  439. Waste disposal‏‎ (2 revisions)
  440. Non-targeted effects‏‎ (2 revisions)
  441. Hounsfield unit‏‎ (2 revisions)
  442. Authorized limit‏‎ (2 revisions)
  443. Planned exposure situation‏‎ (2 revisions)
  444. Progenitor cell‏‎ (2 revisions)
  445. Cardiac arrhythmias‏‎ (2 revisions)
  446. Radiation belt‏‎ (2 revisions - redirect page)
  447. Clonogenic survival‏‎ (2 revisions)
  448. Reasonableness‏‎ (2 revisions)
  449. Cytokines‏‎ (2 revisions)
  450. Residual dose‏‎ (2 revisions)
  451. Safety culture‏‎ (2 revisions)
  452. Solar cosmic radiation‏‎ (2 revisions)
  453. Inhalability‏‎ (2 revisions)
  454. Spontaneous fission‏‎ (2 revisions)
  455. Itinerant (radiation) worker‏‎ (2 revisions)
  456. Linear-non-threshold model‏‎ (2 revisions)
  457. Trapped particles‏‎ (2 revisions)
  458. Acute radiation syndrome‏‎ (2 revisions)
  459. Orphan source‏‎ (2 revisions)
  460. Autoimmune disease‏‎ (2 revisions)
  461. Platelet-derived growth factor‏‎ (2 revisions)
  462. ICRP Publication 118‏‎ (2 revisions)
  463. Cardiac valve diseases‏‎ (2 revisions)
  464. Radiation modifier‏‎ (2 revisions)
  465. Radiological protection principles‏‎ (2 revisions)
  466. Respiratory protection‏‎ (2 revisions)
  467. Disposal‏‎ (2 revisions)
  468. Scintigraphy‏‎ (2 revisions)
  469. Dose criteria‏‎ (2 revisions)
  470. Solar cycle‏‎ (2 revisions)
  471. Inner bremsstrahlung‏‎ (2 revisions)
  472. Environmental exposure‏‎ (2 revisions)
  473. Systemic model‏‎ (2 revisions)
  474. Linear-quadratic dose response model‏‎ (2 revisions)
  475. Exempt waste‏‎ (2 revisions)
  476. Time factor‏‎ (2 revisions)
  477. Myocardial perfusion‏‎ (2 revisions)
  478. Adaptive response‏‎ (2 revisions)
  479. What is Radon?‏‎ (2 revisions)
  480. Alveolar-interstitial region‏‎ (2 revisions)
  481. Projected dose‏‎ (2 revisions)
  482. Co-expertise‏‎ (2 revisions)
  483. Radionuclides of natural origin‏‎ (2 revisions)
  484. Connective tissue‏‎ (2 revisions)
  485. Recovery (cellular or tissue)‏‎ (2 revisions)
  486. DRL process‏‎ (2 revisions)
  487. Retrievability‏‎ (2 revisions)
  488. Immune system‏‎ (2 revisions)
  489. Institutional control‏‎ (2 revisions)
  490. Stakeholder‏‎ (2 revisions)
  491. Environmental radiation protection‏‎ (2 revisions)
  492. Tachycardia‏‎ (2 revisions)
  493. Exemption level‏‎ (2 revisions)
  494. Tissue equivalent material‏‎ (2 revisions)
  495. Myocardial stress test‏‎ (2 revisions)
  496. Oversight‏‎ (2 revisions)
  497. Hyperbaric oxygen‏‎ (2 revisions)
  498. Bioturbation‏‎ (2 revisions)
  499. Cardioverter-defibrillator‏‎ (2 revisions)
  500. Radiation safety officer‏‎ (2 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)